• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TEOXANE SA TEOSYAL RHA 4; DERMAL FILLER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TEOXANE SA TEOSYAL RHA 4; DERMAL FILLER Back to Search Results
Model Number NOT APPLICABLE
Device Problem Insufficient Information (3190)
Patient Problems Skin Infection (4544); Subcutaneous Nodule (4548)
Event Date 09/30/2021
Event Type  Injury  
Manufacturer Narrative
Additional mfr narrative: batch data review : quality controls of the related product's batch records have been performed.The product is compliant with specifications.No defect has been highlighted during production.Batch history : another complaint was registered to date for this batch number : rc/2105130, for a needle ejection, unrelated to the present complaint.Corrected data: the injector requested medical assistance and was put in contact with a local medical expert.
 
Event Description
This case occured outside of the usa, in (b)(6).According to the information received on (b)(6) 2021, a patient was injected on (b)(6) 2021 with a teosyal rha 4 product (tpul-203022c0), 1.2ml, in the marionette lines.Six months later, on (b)(6) 2021, the patient complained about nodules of severe intensity in the injected areas, and was treated with corticoids (prednisolone during 7 days).The injector requested medical assistance and was put in contact with a local medical expert to discuss the management of this adverse event.On (b)(6) 2021, we were informed that the corticoids did not have any effect on the nodules and that a skin infection was suspected.On (b)(6) 2021, the injector reported that the event worsened despite 2 weeks treatment of high dose corticosteroids, and decided to inject the patient with hyaluronidase.Considering this information, we decided to update the reportability of this case.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TEOSYAL RHA 4
Type of Device
DERMAL FILLER
Manufacturer (Section D)
TEOXANE SA
rue de lyon
105
geneva 1203
CH  1203
Manufacturer (Section G)
TEOXANE SA
rue de lyon
105
geneva 1203
CH   1203
Manufacturer Contact
nicolas caill
rue de lyon
105
geneva 1203
CH   1203
022344-963
MDR Report Key12786388
MDR Text Key281680182
Report Number3005975625-2021-00607
Device Sequence Number1
Product Code LMH
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P170002,
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 11/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/10/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/31/2022
Device Model NumberNOT APPLICABLE
Device Catalogue NumberNOT APPLICABLE
Device Lot NumberTPUL-203022C0
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? No
Date Device Manufactured07/31/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age54 YR
Patient SexFemale
-
-